Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
51.68%
Threshold
Crossed downwards
Timeline
Published
23.02.2021
Transaction
15.02.2021
Voting rights breakdown
Voting rights acquired9.91%
Voting rights sold51.68%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAL2I00032
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, Pratteln
regarding certain sales positions
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open